Jayson Rieger - 14 Aug 2026 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Reporting relationship: CEO and President, Director
Issuer ticker: VRCA
Reported as of: 14 Aug 2026
Net transaction value: +$125,750
SEC form: 4
Accepted by SEC: 18 Aug 2026, 17:00:14 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jayson Rieger

Key filing fact

Jayson Rieger filed Form 4 for Verrica Pharmaceuticals Inc. (VRCA) on 18 Aug 2026.

Key facts

This page summarizes Jayson Rieger's Form 4 filing for Verrica Pharmaceuticals Inc. (VRCA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: +$125,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002043558 Primary reporting owner

Rieger Jayson

Relationship: CEO and President, Director
Address: C/O VERRICA PHARMACEUTICALS INC., 44 W. GAY ST., SUITE 400, WEST CHESTER
Signature: /s/ Jayson Rieger
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRCA transaction

Common Stock

Purchase

Transaction value: $101,200
Shares: +20,000
Change %: +11%
Price: $5.06
Shares after: 202,593
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1

VRCA transaction

Common Stock

Purchase

Transaction value: $24,550
Shares: +5,000
Change %: +2.5%
Price: $4.91
Shares after: 207,593
Date: 17 Aug 2026
Ownership: Direct

VRCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15
Date: 14 Aug 2026
Ownership: By child

VRCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 230
Date: 14 Aug 2026
Ownership: By trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person is a co-trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.